Effect of Non-invasive Neuromodulation on the Quality of Intestinal Cleansing

Inclusion criteria

• 18 to 78 years of age, male or female;
• Intended to undergo diagnostic, screening, or surveillance colonoscopy;
• Signed written informed consent.

Exclusion criteria

• Severe cardiac, cerebral, pulmonary, or renal complications or a history of acute cardiac infarction within six months;
• High risk factors for bowel preparation such as history of colon surgery, BMI ≥ 28, inflammatory bowel disease, constipation (less than 3 bowel movements in the last week, and with straining to defecate, with hard stools and small amount of stools) or bowel obstruction;
• High suspicion of colorectal cancer by auxiliary examination or early warning signs and symptoms of colorectal cancer: blood in stool, black stool, unexplained anemia, significant weight loss, abdominal mass and positive rectal fingerprinting;
• The presence of surgical incisions or scars in the area where the electrostimulation treatment tablets are pasted, or near the ST36 acupoints on both legs;
• Are participating in other clinical observation trials or have participated in other clinical trials within 30 days.